title: Current scenario of spurious and substandard medicines in India: a systematic review.
abstract: Globally, every country is the victim of substandard or spurious drugs, which result in life threatening issues, financial loss of consumer and manufacturer and loss in trust on health system. The aim of this enumerative review was to probe the extent on poor quality drugs with their consequences on public health and the preventive measures taken by the Indian pharmaceutical regulatory system. Government and non-government studies, literature and news were gathered from journals and authentic websites. All data from 2000 to 2013 were compiled and interpreted to reveal the real story of poor quality drugs in India. For minimizing spurious/falsely-labelled/falsified/counterfeit drugs or not of standard quality drugs, there is urgent requirement of more stringent regulation and legal action against the problem. However, India has taken some preventive steps in the country to fight against the poor quality drugs for protecting and promoting the public health.
authors.affiliation: Department of Pharmacy, Jaypee University of Information Technology, Waknaghat, Solan-173 234, India.
authors.forename: A N
authors.initials: AN
authors.lastname: Khan
authors.affiliation: Department of Pharmaceutics, B. S. Anangpuria Institute of Pharmacy, Alampur, Faridabad-121 001, India.
authors.forename: R K
authors.initials: RK
authors.lastname: Khar
keywords: Central Drugs Standard Control Organization; SFFC; poor quality drugs; whistle blower scheme